These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33223495)

  • 41. Can psychological features predict antidepressant response to rTMS? A Discovery-Replication approach.
    Krepel N; Rush AJ; Iseger TA; Sack AT; Arns M
    Psychol Med; 2020 Jan; 50(2):264-272. PubMed ID: 30674359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Baseline effective connectivity predicts response to repetitive transcranial magnetic stimulation in patients with treatment-resistant depression.
    Iwabuchi SJ; Auer DP; Lankappa ST; Palaniyappan L
    Eur Neuropsychopharmacol; 2019 May; 29(5):681-690. PubMed ID: 30827757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Baseline and treatment-emergent EEG biomarkers of antidepressant medication response do not predict response to repetitive transcranial magnetic stimulation.
    Widge AS; Avery DH; Zarkowski P
    Brain Stimul; 2013 Nov; 6(6):929-31. PubMed ID: 23763894
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Parieto-temporal alpha EEG band power at baseline as a predictor of antidepressant treatment response with repetitive Transcranial Magnetic Stimulation: a preliminary study.
    Micoulaud-Franchi JA; Richieri R; Cermolacce M; Loundou A; Lancon C; Vion-Dury J
    J Affect Disord; 2012 Mar; 137(1-3):156-60. PubMed ID: 22244378
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of the loudness dependence of auditory evoked potentials with clinical changes to repetitive transcranial magnetic stimulation in patients with depression.
    Lee S; Jang KI; Chae JH
    J Affect Disord; 2018 Oct; 238():451-457. PubMed ID: 29920440
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Accelerated intermittent theta burst stimulation treatment in medication-resistant major depression: A fast road to remission?
    Duprat R; Desmyter S; Rudi de R; van Heeringen K; Van den Abbeele D; Tandt H; Bakic J; Pourtois G; Dedoncker J; Vervaet M; Van Autreve S; Lemmens GM; Baeken C
    J Affect Disord; 2016 Aug; 200():6-14. PubMed ID: 27107779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prefrontal cortical blood flow predicts response of depression to rTMS.
    Weiduschat N; Dubin MJ
    J Affect Disord; 2013 Sep; 150(2):699-702. PubMed ID: 23707032
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of Repetitive Transcranial Magnetic Stimulation Treatment With Subgenual Cingulate Hyperactivity in Patients With Major Depressive Disorder: A Secondary Analysis of a Randomized Clinical Trial.
    Hadas I; Sun Y; Lioumis P; Zomorrodi R; Jones B; Voineskos D; Downar J; Fitzgerald PB; Blumberger DM; Daskalakis ZJ
    JAMA Netw Open; 2019 Jun; 2(6):e195578. PubMed ID: 31167023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Theta-Burst Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder.
    Philip NS; Barredo J; Aiken E; Larson V; Jones RN; Shea MT; Greenberg BD; van 't Wout-Frank M
    Am J Psychiatry; 2019 Nov; 176(11):939-948. PubMed ID: 31230462
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transcranial Magnetic Stimulation Modulates Resting EEG Functional Connectivity Between the Left Dorsolateral Prefrontal Cortex and Limbic Regions in Medicated Patients With Treatment-Resistant Depression.
    Kito S; Hasegawa T; Takamiya A; Noda T; Nakagome K; Higuchi T; Koga Y
    J Neuropsychiatry Clin Neurosci; 2017; 29(2):155-159. PubMed ID: 27852164
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Using pre-treatment electroencephalography data to predict response to transcranial magnetic stimulation therapy for major depression.
    Khodayari-Rostamabad A; Reilly JP; Hasey GM; deBruin H; MacCrimmon D
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():6418-21. PubMed ID: 22255807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prospective Validation That Subgenual Connectivity Predicts Antidepressant Efficacy of Transcranial Magnetic Stimulation Sites.
    Weigand A; Horn A; Caballero R; Cooke D; Stern AP; Taylor SF; Press D; Pascual-Leone A; Fox MD
    Biol Psychiatry; 2018 Jul; 84(1):28-37. PubMed ID: 29274805
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trajectories of Response to Dorsolateral Prefrontal rTMS in Major Depression: A THREE-D Study.
    Kaster TS; Downar J; Vila-Rodriguez F; Thorpe KE; Feffer K; Noda Y; Giacobbe P; Knyahnytska Y; Kennedy SH; Lam RW; Daskalakis ZJ; Blumberger DM
    Am J Psychiatry; 2019 May; 176(5):367-375. PubMed ID: 30764649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early change of prefrontal theta cordance and occipital alpha asymmetry in the prediction of responses to antidepressants.
    Bares M; Novak T; Vlcek P; Hejzlar M; Brunovsky M
    Int J Psychophysiol; 2019 Sep; 143():1-8. PubMed ID: 31195067
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The lasting effects of 1Hz repetitive transcranial magnetic stimulation on resting state EEG in healthy subjects.
    Qiu S; Wang S; Yi W; Zhang C; He H
    Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():5918-5922. PubMed ID: 31947196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pregenual or subgenual anterior cingulate cortex as potential effective region for brain stimulation of depression.
    Jing Y; Zhao N; Deng XP; Feng ZJ; Huang GF; Meng M; Zang YF; Wang J
    Brain Behav; 2020 Apr; 10(4):e01591. PubMed ID: 32147973
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Electrophysiological differences between high and low frequency rTMS protocols in depression treatment.
    Valiulis V; Gerulskis G; Dapšys K; Vištartaite G; Šiurkute A; Mačiulis V
    Acta Neurobiol Exp (Wars); 2012; 72(3):283-95. PubMed ID: 23093015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Machine learning approaches and non-linear processing of extracted components in frontal region to predict rTMS treatment response in major depressive disorder.
    Ebrahimzadeh E; Fayaz F; Rajabion L; Seraji M; Aflaki F; Hammoud A; Taghizadeh Z; Asgarinejad M; Soltanian-Zadeh H
    Front Syst Neurosci; 2023; 17():919977. PubMed ID: 36968455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study.
    Baskaran A; Farzan F; Milev R; Brenner CA; Alturi S; Pat McAndrews M; Blier P; Evans K; Foster JA; Frey BN; Giacobbe P; Lam RW; Leri F; MacQueen GM; Müller DJ; Parikh SV; Rotzinger S; Soares CN; Strother SC; Turecki G; Kennedy SH;
    J Affect Disord; 2018 Feb; 227():542-549. PubMed ID: 29169123
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simultaneous rTMS and psychotherapy in major depressive disorder: Clinical outcomes and predictors from a large naturalistic study.
    Donse L; Padberg F; Sack AT; Rush AJ; Arns M
    Brain Stimul; 2018; 11(2):337-345. PubMed ID: 29174304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.